Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 667

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 667
---
 with the Exclusivity Agreement of $300,000 paid by TuHURA in October 2024, the
Existing Advances already made by TuHURA to Kineta in connection with the Exclusivity Agreement in the aggregate amount of $694,503 which were loaned by TuHURA prior to the execution of the CTF Agreement and the Merger Agreement but were also
incorporated thereon to aggregate with any forthcoming Advances made under the CTF Agreement, and $750,000 of working capital loans already extended and assumed to be extended by TuHURA to Kineta subsequent to December 31, 2024, in accordance
with the Merger Agreement, as amended in April 2025). See paragraph below for treatment of the cash consideration when the amount already paid in cash that is able to be credited against the base consideration value exceeds the estimated cash
consideration amount.

After incorporating the current estimated working capital deficit and creditable payments already made by TuHURA to
Kineta, the estimated amount of cash to be paid at Closing for the cash component of the aggregate Merger Consideration (the “Closing Adjusted Cash Consideration”) is currently estimated to be a negative amount of $744,503 ($6,000,000 less
the $6,744,503 already paid). Pursuant to the Merger Agreement, if and only if the Closing Adjusted Cash Consideration is less than zero, then this negative amount’s absolute value will be defined as the Deficit Cash Consideration which
accordingly reduces the Initial Share Consideration. The actual Closing Adjusted Cash Consideration paid, including the calculation of potential Deficit Cash Consideration subject to adjustment pursuant to the amended Merger Agreement based on the
final net working capital deficit or surplus of Kineta at the Closing and certain subsequent working capital loans made by TuHURA to Kineta between the date of the Merger Agreement and closing of the Mergers not related to the funding under the CTF
Agreement with such loans and their terms made in contemplation within the Merger Agreement, as amended in April 2025. Accordingly, based on the estimated net working capital deficit of $6,000,000 and other cash payments able to be credited against
the base cash consideration in the total Merger Consideration noted above, this unaudited pro forma condensed combined financial information assumes a Deficit Cash Consideration of $744,503 as calculated above.

The maximum estimated share consideration, which is ultimately subject to adjustment pursuant to